AJIC: American Journal of Infection Control
Volume 38, Issue 1 , Pages 56-58 , February 2010

Preventive effect of meningococcal vaccination in Israeli military recruits

  • Daniel Mimouni, MD

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • Department of Dermatology, Rabin Medical Center, Beilinson Campus, Petah Tiqwa, Israel
    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    • Corresponding Author InformationAddress correspondence to Daniel Mimouni, MD, Department of Dermatology, Rabin Medical Center, 3 Hashdema Street, Ramat-Hasharon, Israel 47445.
    • ,
  • Yael Bar-Zeev, MD, MPH

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • ,
  • Michael Huerta, MD, MPH

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • Department of Epidemiology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Ran D. Balicer, MD, MPH

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • Department of Epidemiology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Itamar Grotto, MD, MPH

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • Department of Epidemiology, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
    • ,
  • Omer Ankol, MD, MPH

      Affiliations

    • Medical Corps, Israel Defense Forces, Ramat Gan, Israel
    • Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

References 

  1. Stroffolini T. Vaccination campaign against meningococcal disease in army recruits in Italy. Epidemiol Infect. 1990;105:579–583
  2. Taha M, Achtman M, Alonso JM, Greenwood B, Ramsay M, Fox A, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356:2159
  3. Mimouni D, Gdalevich M, Mandel Y, Haim M, Ashkenazi I, Shemer J, et al. Meningococcal polysaccharide vaccination of military recruits in Israel: preliminary assessment of vaccine effect. Scand J Infect Dis. 1998;30:263–264
  4. Caugant DA, Hoiby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32:323–330
  5. World Health Organization Media Centre. Available from: http://www.who.int/mediacentre/factsheets/fs141/en/index.html. Accessed August 12, 2009.
  6. Grotto I, Block C, Lerman Y, Wiener M, Ashkenazi S. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges. Isr J Med Sci. 1995;31:54–58
  7. Peltola H. Meningococcal disease: still with us. Rev Infect Dis. 1983;5:71–91
  8. Fredlund H. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis: studies of interactions with special reference to a chemiluminometric technique. Scand J Infect Dis. 1993;S87:1–72
  9. Paret G, Keller N, Barzilai A, Zemach M, Guttman D, Vardi A, et al. Invasive meningococcal disease: patient and strain characteristics set new challenge for prevention and control. Infection. 1999;27:261–264
  10. Nikoskelainen J, Leino A, Lahtonen E, Kalliomaki JL, Toivanen A. Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci?. Lancet. 1978;2:403–405
  11. Israel Ministry of Health, Epidemiology Department. Available from: http://www.health.gov.il/pages/default.asp?maincat=9&catId=40. Accessed August 12, 2009.
  12. Holst J. Strategies for development of universal vaccines against meningococcal serogroup B disease: the most promising options and the challenges evaluating them. Hum Vaccin. 2007;3:290–294
  13. Biselli R, Fattorossi A, Matricardi PM, Nisini R, Stroffolini T. D'Amelio R. Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine. 1993;11:578–581
  14. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: emergence of a virulent clone of Neisseria meningitidis. JAMA. 1995;273:390–394

PII: S0196-6553(09)00623-3

doi: 10.1016/j.ajic.2009.04.290

AJIC: American Journal of Infection Control
Volume 38, Issue 1 , Pages 56-58 , February 2010

Article Tools

* Image Usage & Resolution